These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23528740)

  • 1. Complement activation by PEGylated liposomes containing prednisolone.
    van den Hoven JM; Nemes R; Metselaar JM; Nuijen B; Beijnen JH; Storm G; Szebeni J
    Eur J Pharm Sci; 2013 May; 49(2):265-71. PubMed ID: 23528740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
    Dézsi L; Fülöp T; Mészáros T; Szénási G; Urbanics R; Vázsonyi C; Őrfi E; Rosivall L; Nemes R; Kok RJ; Metselaar JM; Storm G; Szebeni J
    J Control Release; 2014 Dec; 195():2-10. PubMed ID: 25148822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.
    Moghimi SM; Hamad I; Andresen TL; Jørgensen K; Szebeni J
    FASEB J; 2006 Dec; 20(14):2591-3. PubMed ID: 17065229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
    Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
    Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
    ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes.
    van den Hoven JM; Metselaar JM; Storm G; Beijnen JH; Nuijen B
    Int J Pharm; 2012 Nov; 438(1-2):209-16. PubMed ID: 22960501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ; Devine DV; Ansell SM; Janzen J; Brooks DE
    Arch Biochem Biophys; 1998 Sep; 357(2):185-94. PubMed ID: 9735159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged blood concentration of prednisolone after intravenous injection of liposomal palmitoyl prednisolone.
    Teshima M; Fumoto S; Nishida K; Nakamura J; Ohyama K; Nakamura T; Ichikawa N; Nakashima M; Sasaki H
    J Control Release; 2006 May; 112(3):320-8. PubMed ID: 16631272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
    Wang X; Ishida T; Kiwada H
    J Control Release; 2007 Jun; 119(2):236-44. PubMed ID: 17399838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
    Dézsi L; Mészáros T; Őrfi E; Fülöp TG; Hennies M; Rosivall L; Hamar P; Szebeni J; Szénási G
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
    Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 354(1-2):56-62. PubMed ID: 18083313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.
    Szebeni J; Baranyi L; Savay S; Milosevits J; Bunger R; Laverman P; Metselaar JM; Storm G; Chanan-Khan A; Liebes L; Muggia FM; Cohen R; Barenholz Y; Alving CR
    J Liposome Res; 2002; 12(1-2):165-72. PubMed ID: 12604051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-induced hypersensitivity reactions: Risk reduction by design of safe infusion protocols in pigs.
    Fülöp T; Kozma GT; Vashegyi I; Mészáros T; Rosivall L; Urbanics R; Storm G; Metselaar JM; Szebeni J
    J Control Release; 2019 Sep; 309():333-338. PubMed ID: 31295544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of interfacial cholesterol-anchored polyethylene glycol on sterol-rich non-phospholipid liposomes.
    Cui ZK; Edwards K; Nieto Orellana A; Bastiat G; Benoit JP; Lafleur M
    J Colloid Interface Sci; 2014 Aug; 428():111-20. PubMed ID: 24910042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.
    Ishida T; Ichikawa T; Ichihara M; Sadzuka Y; Kiwada H
    J Control Release; 2004 Mar; 95(3):403-12. PubMed ID: 15023452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
    Szebeni J; Muggia F; Gabizon A; Barenholz Y
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1020-30. PubMed ID: 21787819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.